Ubiquitin-Proteasome
Pathway
Discover how cells selectively tag and degrade damaged or unneeded proteins through an elegant multi-enzyme cascade and barrel-shaped protease.
Biochemistry
Why Do Cells Destroy Their Own Proteins?
Proteins are not permanent. They become misfolded, damaged, or simply no longer needed. Without a cleanup mechanism, toxic aggregates would accumulate and disrupt cellular function. Regulated protein degradation controls the cell cycle, immune signaling, and quality control.
Meet Ubiquitin: The Molecular Tag
76 Amino Acids
A small, highly conserved protein found in virtually all eukaryotic cells: hence "ubiquitous."
C-Terminal Glycine
Forms an isopeptide bond with the \(\varepsilon\)-amino group of a lysine residue on the target protein.
Lys48 Chains
Polyubiquitin chains linked through Lys48 serve as the primary signal for proteasomal degradation.
The Three-Enzyme Cascade
Step-by-Step Ubiquitination Mechanism
1
Activation: E1 activates ubiquitin in an ATP-dependent reaction, forming a high-energy E1~Ub thioester bond via the active-site cysteine.
2
Conjugation: Activated ubiquitin is transferred from E1 to the active-site cysteine of an E2 conjugating enzyme via a transthiolation reaction.
3
Ligation: The E3 ligase binds both the E2~Ub and the substrate, catalyzing isopeptide bond formation between Ub's C-terminal Gly and the substrate's Lys \(\varepsilon\)-amino group.
4
Chain elongation: Steps 1-3 repeat to build a polyubiquitin chain (minimum 4 Ub linked via Lys48) that serves as the degradation signal.
The 26S Proteasome: Molecular Shredder
Two Major E3 Ligase Families
HECT Domain
Ubiquitin is first transferred to an active-site cysteine on E3 before being passed to the substrate. The E3 forms a Ub~E3 thioester intermediate.
RING Domain
E3 acts as a scaffold, bringing E2~Ub and the substrate into proximity. Ubiquitin transfers directly from E2 to substrate: no E3 intermediate.
UPS vs Lysosomal Degradation
| Ubiquitin-Proteasome | Lysosome / Autophagy | |
|---|---|---|
| Location | Cytosol & nucleus | Membrane-bound organelle |
| Selectivity | Highly selective (Ub tag) | Bulk or selective (receptors) |
| Targets | Short-lived, regulatory proteins | Organelles, aggregates, long-lived proteins |
| Energy | ATP-dependent (tagging + unfolding) | ATP for acidification |
| Products | Short peptides (7-9 aa) | Amino acids, lipids, sugars |
| pH | Neutral (~7.2) | Acidic (~4.5-5.0) |
Biological Roles of the UPS
Cell Cycle
Cyclins are degraded by the APC/C (an E3 ligase) to drive progression through mitosis and prevent re-replication.
Immune Response
Proteasome-generated peptides are loaded onto MHC class I for antigen presentation to cytotoxic T cells.
Quality Control
The ERAD pathway extracts misfolded ER proteins and routes them to the proteasome, preventing toxic accumulation.
How to Identify a UPS Target
1
Recognize the signal: Does the protein contain a degron (destruction motif, phosphodegron, or N-end rule residue)?
2
Identify the E3: Which E3 ligase recognizes this degron? Is it a RING type (e.g., SCF, APC/C) or HECT type (e.g., E6AP)?
3
Check the chain type: Is the polyubiquitin chain linked through Lys48 (degradation) or Lys63 (signaling, not degradation)?
4
Predict the outcome: What biological process is regulated by this protein's removal (cell cycle, inflammation, DNA repair)?
Example 1: Cyclin B Degradation
Example 2: p53 and MDM2
Example 3: NF-\(\kappa\)B Activation via I\(\kappa\)B Degradation
1
Resting state: NF-\(\kappa\)B is sequestered in the cytoplasm by its inhibitor I\(\kappa\)B\(\alpha\).
2
Signal: Pro-inflammatory stimuli (e.g., TNF\(\alpha\)) activate IKK kinase, which phosphorylates I\(\kappa\)B\(\alpha\) on Ser32 and Ser36.
3
Recognition: Phosphorylated I\(\kappa\)B\(\alpha\) is recognized by the SCF\(\beta\)-TrCP E3 ligase complex and polyubiquitinated via Lys48 chains.
4
Outcome: The 26S proteasome degrades I\(\kappa\)B\(\alpha\), freeing NF-\(\kappa\)B to translocate to the nucleus and activate immune response genes.
DUBs: Reversing the Ubiquitin Signal
Deubiquitinating enzymes (DUBs) are proteases that remove ubiquitin from target proteins, providing an editing and recycling mechanism. The human genome encodes roughly ~100 DUBs across several families.
Rescue
DUBs can remove ubiquitin chains before the proteasome engages, saving proteins from degradation.
Recycle
The 19S cap contains DUBs (e.g., USP14, RPN11) that cleave Ub chains during degradation, recycling free ubiquitin.
Edit
DUBs can trim or remodel chain types, switching a protein from a degradation signal to a signaling function.
UPS in Disease
Cancer
MDM2 overexpression degrades p53. Mutations in VHL (an E3 ligase) cause renal cell carcinoma by failing to degrade HIF-1\(\alpha\).
Neurodegeneration
Parkin (an E3 ligase) mutations cause Parkinson's disease. Impaired proteasome function leads to aggregation of \(\alpha\)-synuclein.
Therapy
Bortezomib (proteasome inhibitor) treats multiple myeloma by blocking degradation of pro-apoptotic factors and I\(\kappa\)B\(\alpha\).
Common Mistakes
✕ All Ub Chains = Degradation
Only Lys48-linked polyubiquitin targets proteins for proteasomal degradation. Lys63 chains signal DNA repair, endocytosis, or NF-\(\kappa\)B activation.
✕ E3 Is Just One Enzyme
E3 ligases are a vast family (~600+) with distinct substrate specificities. Different E3s target different proteins: APC/C for cyclins, MDM2 for p53, VHL for HIF-1\(\alpha\).
✕ Ubiquitin Is Consumed
Ubiquitin is recycled by DUBs at the proteasome. It is a reusable tag, not a one-time-use label. The cell maintains a ubiquitin pool.
Pathway Summary
| Component | Function | Key Detail |
|---|---|---|
| E1 | Activates ubiquitin | ATP-dependent thioester |
| E2 | Carries activated Ub | ~40 variants in humans |
| E3 | Substrate recognition | RING or HECT; ~600+ types |
| Ubiquitin | Degradation tag | 76 aa; Lys48 chain = degrade |
| 26S Proteasome | Protein destruction | 19S (unfold) + 20S (cleave) |
| DUBs | Remove Ub / rescue | ~100 in human genome |
Question 1 of 5
Which enzyme in the ubiquitin-proteasome pathway is primarily responsible for substrate specificity?
The E3 ligase determines which protein gets ubiquitinated. With ~600+ E3s in the human genome (versus only ~2 E1s and ~40 E2s), substrate specificity is overwhelmingly controlled at the E3 level.
Question 2 of 5
A polyubiquitin chain linked through Lys48 primarily signals a protein for:
Lys48-linked polyubiquitin chains are the canonical signal for proteasomal degradation. Other chain types (e.g., Lys63) mediate non-degradative signaling such as DNA repair and NF-\(\kappa\)B activation.
Question 3 of 5
In the regulation of p53, what happens when MDM2 is overexpressed?
MDM2 is the E3 ligase for p53. Overexpression of MDM2 leads to excessive ubiquitination and degradation of p53, removing its tumor-suppressive functions (cell cycle arrest, apoptosis, DNA repair), which promotes cancer development.
Question 4 of 5
How does the RING domain E3 ligase differ from the HECT domain E3 ligase in ubiquitin transfer?
RING E3s act as scaffolds, facilitating direct transfer from E2 to substrate. HECT E3s accept ubiquitin onto their own active-site cysteine first (forming a thioester intermediate), then transfer it to the substrate. This is a fundamental mechanistic distinction.
Question 5 of 5
Bortezomib is a drug used to treat multiple myeloma. It works by inhibiting the proteasome. Why would blocking protein degradation be toxic to cancer cells?
Proteasome inhibition causes accumulation of pro-apoptotic proteins and I\(\kappa\)B\(\alpha\) (which normally gets degraded to activate NF-\(\kappa\)B survival signaling). Cancer cells, which depend heavily on rapid protein turnover and NF-\(\kappa\)B signaling, are particularly vulnerable to this disruption.